Quest
Blueprint Genetics to Analyze Biobank Samples for Rare Diseases in New Finnish Study
Researchers plan to identify and sequence the exomes of 3,000 individuals from the biobank who are likely to have one of a number of rare diseases.
CLX Health, Quest Diagnostics Partnering to Provide COVID-19 Testing for Events, Travel
Individuals will be able to schedule COVID-19 testing appointments at Quest patient centers using CLX's TrustAssure Global Testing Platform.
Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test
The liquid biopsy test is intended for identifying genetic mutations to guide therapy in patients with advanced non-small cell lung cancer.
Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing
The companies have launched an initiative to improve patient access to EZH2 mutation testing for patients with relapsed or refractory follicular lymphoma.
CIC Health, Quest Diagnostics Collaborate on COVID-19 School Testing
Quest will augment CIC Health's lab network, expanding its capacity and allowing it to reach more students and summer program participants.
Dec 20, 2020
Aug 3, 2020
Apr 29, 2020